0,982  0,002  Carcinogenic
0,958  0,004  Antiinflammatory
0,956  0,003  Transcription factor NF kappa B inhibitor
0,949  0,001  Sepsis treatment
0,883  0,004  Prostate cancer treatment
0,865  0,003  Nitric oxide antagonist
0,863  0,009  Apoptosis agonist
0,821  0,007  Antineoplastic (lung cancer)
0,814  0,006  Antineoplastic (colorectal cancer)
0,806  0,006  Antineoplastic (colon cancer)
0,788  0,006  Antileukemic
0,780  0,011  Antineoplastic (breast cancer)
0,678  0,004  DNA intercalator
0,625  0,007  Free radical scavenger
0,629  0,014  Immunostimulant
0,633  0,028  Autoimmune disorders treatment
0,594  0,015  Sensitization
0,540  0,015  Caspase 3 stimulant
0,540  0,016  Antioxidant
0,539  0,019  Antineoplastic (melanoma)
0,502  0,027  Antineoplastic (ovarian cancer)
0,469  0,028  Cytotoxic
0,446  0,058  Antibacterial
0,388  0,015  Contraceptive
0,396  0,028  Chemopreventive
0,377  0,027  Antineoplastic (liver cancer)
0,359  0,035  Sodium/bile acid cotransporter inhibitor
0,335  0,028  Abortion inducer
0,339  0,061  Apoptosis antagonist
0,303  0,026  UGT2B7 substrate
0,324  0,050  Antineoplastic (endocrine cancer)
0,254  0,019  UGT2B9 substrate
0,294  0,059  Antineoplastic (non-small cell lung cancer)
0,273  0,039  UGT1A1 substrate
0,306  0,073  Respiratory analeptic
0,296  0,076  NOS3 expression inhibitor
0,251  0,033  Lipocortins synthesis antagonist
0,246  0,031  Antiacne
0,247  0,036  Antipruritic, non-allergic
0,298  0,090  ICAM1 expression inhibitor
0,228  0,020  Topoisomerase I inhibitor
0,289  0,089  AR expression inhibitor
0,262  0,065  Angiogenesis stimulant
0,242  0,049  Antiviral (Influenza)
0,282  0,090  Antifungal
0,228  0,038  Age-related macular degeneration treatment
0,217  0,032  Toxic, respiratory center
0,234  0,054  UDP-glucuronosyltransferase substrate
0,249  0,073  NOS2 expression inhibitor
0,267  0,096  Analeptic
0,177  0,010  Postmenopausal disorders treatment
0,253  0,087  UGT2B4 substrate
0,203  0,040  Protein kinase stimulant
0,172  0,013  Opioid kappa receptor antagonist
0,184  0,028  Antieczematic
0,200  0,045  Prostate disorders treatment
0,191  0,040  Insulin secretagoues
0,191  0,044  Interferon gamma antagonist
0,165  0,023  Antineoplastic alkaloid
0,156  0,015  Anabolic
0,202  0,067  Mutagenic
0,225  0,097  Proliferative diseases treatment
0,193  0,069  Hepatoprotectant
0,164  0,042  Antifungal (Cryptococcus)
0,203  0,097  Cytostatic
0,137  0,034  Antineoplastic antibiotic
0,130  0,028  Antispirochetal
0,125  0,026  Antibiotic
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,158  0,064  UGT2B15 substrate
0,140  0,050  Cholesterol synthesis inhibitor
0,129  0,040  UGT2B1 substrate
0,097  0,010  Opioid kappa receptor agonist
0,170  0,085  Antirickettsial
0,118  0,037  Opioid antagonist
0,147  0,067  Antineoplastic (squamous cell carcinoma)
0,189  0,114  Peptidyltransferase inhibitor
0,127  0,053  Microtubule formation inhibitor
0,122  0,051  Choleretic
0,094  0,030  Narcotic antagonist
0,081  0,019  Hypercalcemia treatment
0,147  0,086  Melanin inhibitor
0,113  0,052  Toll-Like receptor 4 antagonist
0,080  0,019  Protein 50S ribosomal subunit inhibitor
0,080  0,021  Transcription factor AP-1 inhibitor
0,093  0,034  Opioid mu receptor antagonist
0,124  0,067  Antiviral (Hepatitis B)
0,143  0,097  Arachidonic acid antagonist
0,201  0,154  Hepatic disorders treatment
0,060  0,015  Microtubule stabilization
0,218  0,178  Immunosuppressant
0,135  0,096  UGT1A3 substrate
0,076  0,038  Opioid delta receptor antagonist
0,063  0,030  Lipocortins synthesis agonist
0,133  0,101  Ca2+-transporting ATPase inhibitor
0,051  0,020  Parathyroid hormone antagonist
0,196  0,168  Cholesterol antagonist
0,065  0,038  Antimycoplasmal
0,093  0,071  UGT2B11 substrate
0,066  0,048  Glutamate (mGluR6) antagonist
0,050  0,031  Mineralocorticoid receptor antagonist
0,027  0,009  Vitamin D receptor antagonist
0,048  0,031  Opioid mu receptor agonist
0,035  0,018  RNA-directed RNA polymerase stimulant
0,082  0,066  Transcription factor NF kappa B stimulant
0,078  0,066  Ca(v)3.1 blocker
0,083  0,072  Actinic keratosis treatment
0,138  0,128  UGT2B10 substrate
0,082  0,073  ATPase (Vacuolar H+) inhibitor
0,035  0,027  Glutamate (mGluR8) antagonist
0,018  0,012  Progesterone agonist
0,166  0,163  Antineoplastic (pancreatic cancer)
0,018  0,016  Progesterone receptor B antagonist
0,108  0,107  Antineoplastic (carcinoma)
0,045  0,045  Opioid agonist

